Johnson Johnson Aktie
133,38
EUR
-0,12
EUR
-0,09
%
152,53
USD
-2,75
USD
-1,77
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
| Bayer | 2 | 7 | 0 | 26,00 EUR | -3,44% |
| Beiersdorf AG | 8 | 1 | 2 | 143,70 EUR | +30,93% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +29,22% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 2 | 0 | - | - |
| Douglas | 3 | 1 | 0 | 15,62 EUR | +45,98% |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 48,19 EUR | +1,80% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 49,29 EUR | +14,12% |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,30 GBP | +10,14% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +47,37% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +163,73% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Nestlé SA (Nestle) | 3 | 7 | 1 | 86,50 CHF | +4,49% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +4,37% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +21,31% |
| Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +11,75% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 116,12 EUR | +36,55% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 48,66 GBP | +5,37% |
| Valneva | 0 | 0 | 0 | - | - |